102 related articles for article (PubMed ID: 8137377)
61. Erratum to: A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.
Nomoto H; Takami A; Espinoza JL; Matsuo K; Mizuno S; Onizuka M; Kashiwase K; Morishima Y; Fukuda T; Kodera Y; Doki N; Miyamura K; Mori T; Nakao S; Ohtake S; Morishita E
Int J Hematol; 2015 Oct; 102(4):507-8. PubMed ID: 26351240
[No Abstract] [Full Text] [Related]
62. Myasthenia Gravis After Bone Marrow Transplantation for Chronic Myelocytic Leukemia: Relationship to Chronic Graft versus Host Disease.
Bunyan R; Gardner B; Baize T; Mudd L; Herzig R; Hasan A; Swenson M
J Clin Neuromuscul Dis; 2002 Mar; 3(3):136-7. PubMed ID: 19078669
[No Abstract] [Full Text] [Related]
63. [Myositis as a manifestation of chronic graft-versus-host disease] [In Process Citation].
Takahashi K; Kashihara K; Shinagawa K; Yoshino T; Abe K; Harada M
Nihon Naika Gakkai Zasshi; 2000 Jul; 89(7):1379-84. PubMed ID: 10934766
[No Abstract] [Full Text] [Related]
64. Acute Hair Loss 3 Years after Bone Marrow Transplant.
Silva L; De Fraia Souza MN; Teixeira S; Sternberg F; Dumet Fernandes J
Skin Appendage Disord; 2019 Jun; 5(4):255-258. PubMed ID: 31367607
[No Abstract] [Full Text] [Related]
65. [Not Available].
de Araújo RL; de Fátima Lyko K; Funke VA; Torres-Pereira CC
Rev Bras Hematol Hemoter; 2014; 36(1):65-8. PubMed ID: 25030674
[No Abstract] [Full Text] [Related]
66. Graft manipulation--a house of cards?
Gee AP
J Hematother; 1994; 3(1):1-2. PubMed ID: 7922003
[No Abstract] [Full Text] [Related]
67. [Apropos of the "graft-versus-host reaction". Study of 4 cases of "heterologous disease"].
SIEGFRIED J
Pathol Biol; 1960 Apr; 8():741-4. PubMed ID: 14446499
[No Abstract] [Full Text] [Related]
68. Erratum to "Salivary Gland Involvement in Chronic Graft-versus-Host Disease: Prevalence, Clinical Significance, and Recommendations for Evaluation" [Biol Blood Marrow Transplant 16:1362-1369].
Imanguli MM; Atkinson JC; Mitchell SA; Avila DN; Bishop RJ; Cowen EW; Datiles MB; Hakim FT; Kleiner DE; Krumlauf MC; Pavletic SZ
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1147. PubMed ID: 27179943
[No Abstract] [Full Text] [Related]
69. Author Correction: Dynamic forecasting of severe acute graft-versus- host disease after transplantation.
Liu X; Cao Y; Guo Y; Gong X; Feng Y; Wang Y; Wang M; Cui M; Guo W; Zhang L; Zhao N; Song X; Zheng X; Chen X; Shen Q; Zhang S; Song Z; Li L; Feng S; Han M; Zhu X; Jiang E; Chen J
Nat Comput Sci; 2022 May; 2(5):342. PubMed ID: 38177828
[No Abstract] [Full Text] [Related]
70. [The reaction of the graft against the host].
AMIEL JL; BINET JL
Bull Mem Soc Med Hop Paris; 1963 Jan 1-8; 114():115-36. PubMed ID: 14041506
[No Abstract] [Full Text] [Related]
71. Correction: Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease.
Waterhouse M; Pennisi S; Pfeifer D; Deuter M; von Bubnoff N; Scherer F; Strüssmann T; Wehr C; Duyster J; Bertz H; Finke J; Duque-Afonso J
Bone Marrow Transplant; 2021 Oct; 56(10):2616. PubMed ID: 34413471
[No Abstract] [Full Text] [Related]
72. Chronische Graft-versus-Host-Erkrankung am männlichen Genitale: eine unterschätzte Manifestation.
Odorici G; Baraldi C; Loi C; Bardazzi F
J Dtsch Dermatol Ges; 2017 Jul; 15(7):746-748. PubMed ID: 28677194
[No Abstract] [Full Text] [Related]
73. Multiple mononeuritis as a manifestation of graft versus host disease.
Muñoz AM; Conca ADG; Luzzi AA; Sosa PS; Sberna F; Comacchio FB; Schutz NP; Bendek GE
Hematol Transfus Cell Ther; 2022 Apr; ():. PubMed ID: 35624017
[No Abstract] [Full Text] [Related]
74. High-choline diets ameliorate acute graft-versus-host disease.
Hu B; Wu D; Xu Y
Blood Sci; 2020 Oct; 2(4):146-147. PubMed ID: 35400024
[No Abstract] [Full Text] [Related]
75. V. TRANSPLANTATION OF BONE, AND SOME USES OF THE BONE GRAFT.
Jones R
Br Med J; 1916 Jul; 2(2896):1-5. PubMed ID: 20768190
[No Abstract] [Full Text] [Related]
76. [Monitoring lymphocyte activity in the peripheral blood of patients after bone marrow transplantation].
Hrabánek J; Lukásová M; Chudomel V; Smetana K
Cas Lek Cesk; 1994 Jan; 133(3):80-2. PubMed ID: 8137377
[TBL] [Abstract][Full Text] [Related]
77. [Allogenic transplantation of bone marrow in childhood].
Starý J; Kobylka P; Kavan P; Komrska V; Syrůcková Z; Vávra V; Sedlácek P; Hrubá A; Frýdl J; Mrácek J
Cas Lek Cesk; 1995 Dec; 134(24):779-84. PubMed ID: 8599820
[TBL] [Abstract][Full Text] [Related]
78. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
Vossen J
Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
[TBL] [Abstract][Full Text] [Related]
79. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
80. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
